79 related articles for article (PubMed ID: 7602110)
1. Antigen-based heteropolymers facilitate, via primate erythrocyte complement receptor type 1, rapid erythrocyte binding of an autoantibody and its clearance from the circulation in rhesus monkeys.
Ferguson PJ; Martin EN; Greene KL; Kuhn S; Cafiso DS; Addona G; Taylor RP
J Immunol; 1995 Jul; 155(1):339-47. PubMed ID: 7602110
[TBL] [Abstract][Full Text] [Related]
2. Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys.
Reist CJ; Liang HY; Denny D; Martin EN; Scheld WM; Taylor RP
Eur J Immunol; 1994 Sep; 24(9):2018-25. PubMed ID: 8088321
[TBL] [Abstract][Full Text] [Related]
3. Primate erythrocyte (E) complement receptor (CR1) as an anchor site for bispecific-based therapies to clear pathogens or autoantibodies safely from the circulation.
Taylor RP; Ferguson PJ
J Hematother; 1995 Oct; 4(5):357-62. PubMed ID: 8581369
[TBL] [Abstract][Full Text] [Related]
4. Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation.
Reist CJ; Combs MJ; Croft BY; Taylor RP
Eur J Immunol; 1993 Nov; 23(11):3021-7. PubMed ID: 8223879
[TBL] [Abstract][Full Text] [Related]
5. Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model.
Taylor RP; Sutherland WM; Martin EN; Ferguson PJ; Reinagel ML; Gilbert E; Lopez K; Incardona NL; Ochs HD
J Immunol; 1997 Jan; 158(2):842-50. PubMed ID: 8993002
[TBL] [Abstract][Full Text] [Related]
6. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
7. Antigen-based heteropolymers. A potential therapy for binding and clearing autoantibodies via erythrocyte CR1.
Ferguson PJ; Reist CJ; Martin EN; Johnson C; Greene KL; Kuhn S; Niebur J; Emlen W; Taylor RP
Arthritis Rheum; 1995 Feb; 38(2):190-200. PubMed ID: 7848309
[TBL] [Abstract][Full Text] [Related]
8. In vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocyte complement receptor.
Taylor RP; Reist CJ; Sutherland WM; Otto A; Labuguen RH; Wright EL
J Immunol; 1992 Apr; 148(8):2462-8. PubMed ID: 1373171
[TBL] [Abstract][Full Text] [Related]
9. Bispecific monoclonal antibody complexes facilitate erythrocyte binding and liver clearance of a prototype particulate pathogen in a monkey model.
Taylor RP; Martin EN; Reinagel ML; Nardin A; Craig M; Choice Q; Schlimgen R; Greenbaum S; Incardona NL; Ochs HD
J Immunol; 1997 Oct; 159(8):4035-44. PubMed ID: 9378993
[TBL] [Abstract][Full Text] [Related]
10. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model.
Kuhn SE; Nardin A; Klebba PE; Taylor RP
J Immunol; 1998 May; 160(10):5088-97. PubMed ID: 9590260
[TBL] [Abstract][Full Text] [Related]
11. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
Schifferli JA; Ng YC; Estreicher J; Walport MJ
J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
[TBL] [Abstract][Full Text] [Related]
12. Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.
Taylor RP; Ferguson PJ; Martin EN; Cooke J; Greene KL; Grinspun K; Guttman M; Kuhn S
Clin Immunol Immunopathol; 1997 Jan; 82(1):49-59. PubMed ID: 9000042
[TBL] [Abstract][Full Text] [Related]
13. Heteropolymers: a novel technology against blood-borne infections.
Mohamed N; Jones SM; Casey LS; Pincus SE; Spitalny GL
Curr Opin Mol Ther; 2005 Apr; 7(2):144-50. PubMed ID: 15844622
[TBL] [Abstract][Full Text] [Related]
14. Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation.
Edberg JC; Kujala GA; Taylor RP
J Immunol; 1987 Aug; 139(4):1240-4. PubMed ID: 3611789
[TBL] [Abstract][Full Text] [Related]
15. A prototype pathogen bound ex vivo to human erythrocyte complement receptor 1 via bispecific monoclonal antibody complexes is cleared to the liver in a mouse model.
Nardin A; Schlimgen R; Holers VM; Taylor RP
Eur J Immunol; 1999 May; 29(5):1581-6. PubMed ID: 10359112
[TBL] [Abstract][Full Text] [Related]
16. Primate erythrocyte-immune complex-clearing mechanism.
Cornacoff JB; Hebert LA; Smead WL; VanAman ME; Birmingham DJ; Waxman FJ
J Clin Invest; 1983 Feb; 71(2):236-47. PubMed ID: 6822663
[TBL] [Abstract][Full Text] [Related]
17. A rapid, fluorescence-based assay for detecting antigenic modulation of the acetylcholine receptor on human cell lines.
Keefe D; Hess D; Bosco J; Tzartos S; Powell J; Lamsa J; Josiah S
Cytometry B Clin Cytom; 2009 May; 76(3):206-12. PubMed ID: 18825779
[TBL] [Abstract][Full Text] [Related]
18. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
Pascual M; Schifferli JA
Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
[TBL] [Abstract][Full Text] [Related]
19. Attachment of biotinylated antibody to red blood cells: antigen-binding capacity of immunoerythrocytes and their susceptibility to lysis by complement.
Muzykantov VR; Taylor RP
Anal Biochem; 1994 Nov; 223(1):142-8. PubMed ID: 7695090
[TBL] [Abstract][Full Text] [Related]
20. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
